BioCentury
ARTICLE | Financial News

Cancer Genetics gains in trading debut

April 5, 2013 11:07 PM UTC

Cancer Genetics Inc. (OTCQB:CGIX) gained $1.25 (13%) to $11.25 in its first day of trading on Friday after the company priced 690,000 shares, including the overallotment, at $10 in a $6.9 million IPO....